MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA. New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and the read through to heart failure,…
Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for traders, including mining and defense stocks, reports on how…
The cleantech sector experienced a dynamic third quarter, with predictions of volatility coming to fruition. While global investment in…
Australian Prime Minister Anthony Albanese and US President Donald Trump signed a rare earths deal during their meeting at…
United States Antimony (NYSE:UAMY) said on Sunday (October 19) that it is proposing to acquire Australian company Larvotto Resources…
Cartier Resources Inc. (″ Cartier ″ or the ″ Company ″) (TSXV: ECR,OTC:ECRFF; FSE: 6CA) is pleased to announce…
China has accused the US of “seriously distorting and exaggerating” Beijing’s newly expanded rare earths export controls, but signaled…
Gold Fields (NYSE:GFI) has completed its AU$3.7 billion purchase of Gold Road Resources. Gold Road rejected Gold Fields’ first…
Manhattan Showing with assay results returning uranium grades ranging from 0.72% to 8.10% U3O8 in outcrop grab samples. Standard…